NCI Cancer Bulletin: A Trusted Source for Cancer Research NewsNCI Cancer Bulletin: A Trusted Source for Cancer Research News
August 9, 2005 • Volume 2 / Number 32 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe

NCI Cancer Bulletin Archive

Page Options

  • Print This Page
  • Print This Document
  • View Entire Document
  • Email This Document
  • View/Print PDF

The information and links on this page are no longer being updated and are provided for reference purposes only.

Featured Article

Search for Colon Cancer Markers Yields Unlikely Target

Researchers have identified a novel biological marker for colon cancer that can be detected in DNA from the stool of some patients with the disease. They used the marker to detect colon cancer in nearly half the DNA samples they analyzed, a result that compares favorably with two noninvasive colon cancer screening tests.

Dr. Sanford Markowitz and his colleagues at Case Western Reserve University and University Hospitals in Cleveland identified the marker, part of a gene called vimentin. They tested it in collaboration with Exact Sciences of Marlborough, Mass., which sells a stool-based DNA test that analyzes about 20 mutations associated with colon cancer.

Unlike those mutations, vimentin has no known role in colon cancer. In fact, the gene is not even active in the normal colon. But it makes a good marker because, in some patients, the gene undergoes a chemical change known as methylation, and this can be detected in DNA from stool.  Read more  

Director's Update

Creating Networks to Foster Progress

I recently wrote a column for a European news syndicate about our 2015 goal and NCI's global outreach. As I stated in the column, eliminating cancer as a cause of suffering and death is something that will involve a global effort from all disciplines and backgrounds working toward this common goal. Cancer is a global problem, and although its solution will involve a global effort, NCI has an opportunity to spearhead this effort.

For that to happen, though, it requires the appropriate infrastructure and networks to facilitate collaboration, and the sharing of information and resources. At NCI, we are strategically focused on building such an infrastructure that can be viewed, to borrow a phrase from HHS Secretary Mike Leavitt, as a "network of networks." In other words, multiple channels through which researchers - in the United States and beyond our borders into Europe, Asia, and elsewhere - can acquire new tools and resources, and communicate and collaborate with others.

The cancer Biomedical Informatics Grid (caBIG) offers an excellent example. Focusing initially on our own National Cancer Program, it is intended to connect cancer centers, Specialized Programs of Research Excellence (SPOREs), NCI's Clinical Trials Cooperative Groups, community clinicians, and others by providing tools for conducting research more effectively and efficiently. But caBIG will by no means be limited to participants in the United States. The National Cancer Act of 1971 called for NCI to pursue its mission both domestically and globally, and I expect that eventually there will be strong international participation in caBIG.  Read more  

The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI). NCI, which was established in 1937, leads the national effort to eliminate the suffering and death due to cancer. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.

For more information on cancer, call 1-800-4-CANCER or visit

NCI Cancer Bulletin staff can be reached at